425: Strive CIO Posts on X.com Regarding Semler Merger

Strive's CIO posted on X.com regarding the proposed business combination with Semler Scientific, emphasizing the strategic and financial benefits.

Summary

• Strive, Inc.'s Chief Investment Officer, Ben Werkman, posted a communication on X.com on October 15, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication includes cautionary statements regarding forward-looking statements related to the transaction's outlook, strategic and financial benefits, timing, and integration.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available, as they will contain important information about both companies and the proposed transaction.
• Strive, Semler Scientific, and certain directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 4

Explanation: The filing is a standard cautionary statement regarding a proposed merger, heavily emphasizing inherent risks and uncertainties associated with forward-looking statements and the transaction itself, rather than presenting overwhelmingly positive news. While the underlying merger is presented as beneficial, the document's primary function is risk disclosure.

Positives

• The proposed business combination is expected to yield strategic and financial benefits for the combined company.
• Management anticipates successful integration of the combined businesses.

Negatives

• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than projected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential for dilution due to Strive's issuance of additional Class A common stock.
• Risk of adverse reactions from customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price could occur before closing.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, partly due to risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact the transaction.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing indicates an outlook of strategic and financial benefits from the proposed business combination, including successful integration and positive impact on future financial performance. However, these forward-looking statements are subject to significant inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., posted the communication on X.com.
• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests Strive's strategic direction involves digital asset integration, aligning with a growing trend of companies exploring or adopting cryptocurrencies for treasury management or investment, which introduces new risk factors to traditional corporate finance. The proposed merger itself is a significant event within the respective industries of the two companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for dilution due to new stock issuance, requirement to vote on the proposed transaction, and potential changes in share price.
• Customers: Risk of adverse reactions or changes to business relationships as a result of the announcement or completion of the transaction.
• Employees: Potential for changes to employee relationships following the announcement or completion of the transaction.
• Management: Diversion of management's attention from ongoing business operations and opportunities during the merger process.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Form S-4 will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing details a proposed business combination between Strive and Semler Scientific, outlining potential strategic and financial benefits alongside significant risks and uncertainties. While the merger could be transformative, the document primarily serves as a cautionary statement, emphasizing potential challenges like integration difficulties, dilution, and market reactions. Investors should hold existing positions and await further detailed financial disclosures in the Form S-4 and Information Statement/Proxy Statement/Prospectus before making new investment decisions, as the full implications and valuation are not yet clear.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury Strategy, Digital Assets, Proxy Solicitation